|
2024-06-20 |
2024-06-20 |
S
Sale
|
KKR Phorm Investors L.P.
Large shareholder
|
24,411,968
-100.0%
5.10
USD 124,501,037
|
24,411,968
-100.0%
|
5.10
|
USD 124,501,037
|
|
|
2024-05-24 |
2024-05-22 |
PS
Planned sale
|
MCFARLAND KATHARINA G.
Non-Executive Director
|
3,996
-4.7%
4.89
USD 19,548
|
3,996
-4.7%
|
4.89
|
USD 19,548
|
|
|
2024-05-24 |
2024-05-22 |
PS
Planned sale
|
Smales Kelly
Non-Executive Director
|
3,996
-5.4%
4.89
USD 19,548
|
3,996
-5.4%
|
4.89
|
USD 19,548
|
|
|
2024-04-26 |
2024-04-24 |
PS
Planned sale
|
Smales Kelly
Non-Executive Director
|
475
-0.6%
4.85
USD 2,304
|
475
-0.6%
|
4.85
|
USD 2,304
|
|
|
2024-04-26 |
2024-04-24 |
PS
Planned sale
|
MCFARLAND KATHARINA G.
Non-Executive Director
|
840
-1.0%
4.85
USD 4,074
|
840
-1.0%
|
4.85
|
USD 4,074
|
|
|
2024-04-05 |
2024-04-04 |
PS
Planned sale
|
Smales Kelly
Non-Executive Director
|
766
-1.0%
4.90
USD 3,753
|
766
-1.0%
|
4.90
|
USD 3,753
|
|
|
2024-03-04 |
2024-02-29 |
S
Sale
|
Parikh Primit
PRESIDENT AND CEO
Executive Director
|
6,000
-1.2%
4.80
USD 28,806
|
6,000
-1.2%
|
4.80
|
USD 28,806
|
|
|
2024-03-01 |
2024-02-28 |
PS
Planned sale
|
MCFARLAND KATHARINA G.
Non-Executive Director
|
3,996
-4.6%
4.81
USD 19,225
|
3,996
-4.6%
|
4.81
|
USD 19,225
|
|
|
2024-03-01 |
2024-02-28 |
PS
Planned sale
|
Smales Kelly
Non-Executive Director
|
3,996
-5.2%
4.81
USD 19,225
|
3,996
-5.2%
|
4.81
|
USD 19,225
|
|
|
2024-01-26 |
2024-01-24 |
PS
Planned sale
|
Smales Kelly
Non-Executive Director
|
471
-0.6%
4.82
USD 2,271
|
471
-0.6%
|
4.82
|
USD 2,271
|
|
|
2024-01-26 |
2024-01-24 |
PS
Planned sale
|
MCFARLAND KATHARINA G.
Non-Executive Director
|
833
-0.9%
4.82
USD 4,015
|
833
-0.9%
|
4.82
|
USD 4,015
|
|
|
2024-01-05 |
2024-01-04 |
PS
Planned sale
|
Smales Kelly
Non-Executive Director
|
766
-1.0%
3.90
USD 2,987
|
766
-1.0%
|
3.90
|
USD 2,987
|
|
|
2024-01-03 |
2024-01-02 |
PS
Planned sale
|
Smales Kelly
Non-Executive Director
|
2,187
-2.7%
3.61
USD 7,895
|
2,187
-2.7%
|
3.61
|
USD 7,895
|
|
|
2023-11-27 |
2023-11-22 |
PS
Planned sale
|
MCFARLAND KATHARINA G.
Non-Executive Director
|
3,995
-4.4%
2.70
USD 10,798
|
3,995
-4.4%
|
2.70
|
USD 10,798
|
|
|
2023-11-27 |
2023-11-22 |
PS
Planned sale
|
Smales Kelly
Non-Executive Director
|
3,995
-4.8%
2.63
USD 10,499
|
3,995
-4.8%
|
2.63
|
USD 10,499
|
|
|
2023-11-21 |
2023-11-20 |
PS
Planned sale
|
MCFARLAND KATHARINA G.
Non-Executive Director
|
3,515
-3.8%
3.01
USD 10,580
|
3,515
-3.8%
|
3.01
|
USD 10,580
|
|
|
2023-11-21 |
2023-11-20 |
PS
Planned sale
|
Smales Kelly
Non-Executive Director
|
656
-0.8%
2.89
USD 1,895
|
656
-0.8%
|
2.89
|
USD 1,895
|
|
|
2023-11-21 |
2023-11-17 |
PS
Planned sale
|
Smales Kelly
Non-Executive Director
|
3,227
-3.7%
2.82
USD 9,094
|
3,227
-3.7%
|
2.82
|
USD 9,094
|
|
|
2023-07-25 |
2023-07-21 |
B
Purchase
|
KKR Phorm Investors L.P.
Large shareholder
|
1,735,988
+7.7%
3.30
USD 5,728,760
|
1,735,988
+7.7%
|
3.30
|
USD 5,728,760
|
|
|
2022-12-01 |
2022-11-30 |
S
Sale
|
Parikh Primit
President and COO
Officer
|
1,648
-0.7%
5.63
USD 9,285
|
1,648
-0.7%
|
5.63
|
USD 9,285
|
|
|
2022-12-01 |
2022-11-29 |
S
Sale
|
Parikh Primit
President and COO
Officer
|
1,852
-0.8%
6.04
USD 11,177
|
1,852
-0.8%
|
6.04
|
USD 11,177
|
|
|
2022-11-28 |
2022-11-23 |
S
Sale
|
Parikh Primit
President and COO
Officer
|
2,000
-0.8%
6.64
USD 13,282
|
2,000
-0.8%
|
6.64
|
USD 13,282
|
|
|
2022-11-21 |
2022-11-17 |
S
Sale
|
McAulay Cameron
Chief Financial Officer
Officer
|
2,806
-3.1%
5.67
USD 15,921
|
2,806
-3.1%
|
5.67
|
USD 15,921
|
|
|
2022-11-21 |
2022-11-17 |
S
Sale
|
Mishra Umesh
Chief Technology Officer
Executive Director
|
1,785
-0.9%
5.67
USD 10,128
|
1,785
-0.9%
|
5.67
|
USD 10,128
|
|
|
2022-11-21 |
2022-11-17 |
S
Sale
|
Parikh Primit
President and COO
Officer
|
8,927
-3.6%
5.67
USD 50,652
|
8,927
-3.6%
|
5.67
|
USD 50,652
|
|
|
2022-11-21 |
2022-11-17 |
S
Sale
|
RIVAS MARIO
Chief Executive Officer
Executive Director
|
3,571
-2.9%
5.67
USD 20,262
|
3,571
-2.9%
|
5.67
|
USD 20,262
|
|
|
2022-03-02 |
2022-02-28 |
S
Sale
|
Parikh Primit
Chief Operating Officer
Officer
|
3,000
-1.2%
7.38
USD 22,131
|
3,000
-1.2%
|
7.38
|
USD 22,131
|
|
|
2021-11-08 |
2021-11-05 |
B
Purchase
|
KKR Phorm Investors L.P.
Large shareholder
|
1,000,000
+4.7%
5.00
USD 5,000,000
|
1,000,000
+4.7%
|
5.00
|
USD 5,000,000
|
|
|
2020-03-13 |
2020-02-12 |
B
Purchase
|
KKR Phorm Investors L.P.
|
1,250,000
+6.3%
4.00
USD 5,000,000
|
1,250,000
+6.3%
|
4.00
|
USD 5,000,000
|
|
|
2020-02-14 |
2020-02-12 |
B
Purchase
|
Tompkins Mark N.
|
25,000
+1.7%
4.00
USD 100,000
|
25,000
+1.7%
|
4.00
|
USD 100,000
|
|
